Cite
Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience.
MLA
Schiavetti, Amalia, et al. “Bevacizumab-Containing Regimen in Relapsed/Progressed Brain Tumors: A Single-Institution Experience.” Child’s Nervous System, vol. 35, no. 6, June 2019, pp. 1007–12. EBSCOhost, https://doi.org/10.1007/s00381-019-04117-z.
APA
Schiavetti, A., Varrasso, G., Mollace, M. G., Dominici, C., Ferrara, E., Papoff, P., & Di Biasi, C. (2019). Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience. Child’s Nervous System, 35(6), 1007–1012. https://doi.org/10.1007/s00381-019-04117-z
Chicago
Schiavetti, Amalia, Giulia Varrasso, Maria Giovanna Mollace, Carlo Dominici, Eva Ferrara, Paola Papoff, and Claudio Di Biasi. 2019. “Bevacizumab-Containing Regimen in Relapsed/Progressed Brain Tumors: A Single-Institution Experience.” Child’s Nervous System 35 (6): 1007–12. doi:10.1007/s00381-019-04117-z.